Follow-The-Filings

NDRA ENDRA Life Sciences

ENDRA Life Sciences earnings company data as of 7:18 PM ET 8/21

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q2 14 Aug EPS 0.06
Rev

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01
10-Q QUARTERLY REPORT
8-K 8.01
8-K 1.01,5.01,7.01,8.01,9.01
8-K 7.01,9.01
8-K 1.01,3.02,8.01,9.01
10-Q QUARTERLY REPORT
8-K 3.01
8-K 2.02,9.01
10-K ANNUAL REPORT
8-K 2.05,7.01,9.01
8-K 5.02,5.03,5.07,9.01
8-K 5.02,9.01
424B4 PROSPECTUS
10-Q QUARTERLY REPORT
8-K 8.01
424B5 PROSPECTUS SUPPLEMENT
8-K 1.01,9.01
DEFA14A DEFA 14A
8-K 7.01,8.01,9.01
8-K 9.01
8-K/A 1.01,1.02,3.02,5.08,7.01,8.01,9.01
10-Q FORM 10-Q
S-1/A FORM S-1/A
8-K 8.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 2 rows shown

Filed Form Detail Links
4 Period Mar 2, 2026 · 2 forms
4 Period Jan 21, 2026 · 3 forms

6 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice